These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 31319371

  • 1. Cinaciguat in combination with insulin induces a favorable effect on implant osseointegration in type 2 diabetic rats.
    Jia T, Wang YN, Zhang J, Hao X, Zhang D, Xu X.
    Biomed Pharmacother; 2019 Oct; 118():109216. PubMed ID: 31319371
    [Abstract] [Full Text] [Related]

  • 2. Genipin and insulin combined treatment improves implant osseointegration in type 2 diabetic rats.
    Zhang J, Wang YN, Jia T, Huang H, Zhang D, Xu X.
    J Orthop Surg Res; 2021 Jan 14; 16(1):59. PubMed ID: 33446235
    [Abstract] [Full Text] [Related]

  • 3. Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes.
    Kalyanaraman H, Schwaerzer G, Ramdani G, Castillo F, Scott BT, Dillmann W, Sah RL, Casteel DE, Pilz RB.
    Diabetes; 2018 Apr 14; 67(4):607-623. PubMed ID: 29301852
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D3 and insulin combined treatment promotes titanium implant osseointegration in diabetes mellitus rats.
    Wu YY, Yu T, Yang XY, Li F, Ma L, Yang Y, Liu XG, Wang YY, Gong P.
    Bone; 2013 Jan 14; 52(1):1-8. PubMed ID: 22985888
    [Abstract] [Full Text] [Related]

  • 5. Activation of soluble guanylyl cyclase signalling with cinaciguat improves impaired kidney function in diabetic mice.
    Harloff M, Prüschenk S, Seifert R, Schlossmann J.
    Br J Pharmacol; 2022 Jun 14; 179(11):2460-2475. PubMed ID: 33651375
    [Abstract] [Full Text] [Related]

  • 6. The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus.
    Mátyás C, Németh BT, Oláh A, Hidi L, Birtalan E, Kellermayer D, Ruppert M, Korkmaz-Icöz S, Kökény G, Horváth EM, Szabó G, Merkely B, Radovits T.
    Cardiovasc Diabetol; 2015 Oct 31; 14():145. PubMed ID: 26520063
    [Abstract] [Full Text] [Related]

  • 7. Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats.
    Czirok S, Fang L, Radovits T, Szabó G, Szénási G, Rosivall L, Merkely B, Kökény G.
    Sci Rep; 2017 Sep 11; 7(1):11218. PubMed ID: 28894114
    [Abstract] [Full Text] [Related]

  • 8. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    Reinke Y, Gross S, Eckerle LG, Hertrich I, Busch M, Busch R, Riad A, Rauch BH, Stasch JP, Dörr M, Felix SB.
    Eur J Pharmacol; 2015 Nov 15; 767():1-9. PubMed ID: 26407652
    [Abstract] [Full Text] [Related]

  • 9. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN, Das A, Samidurai A, Hoke NN, Chau VQ, Ockaili RA, Stasch JP, Kukreja RC.
    Am J Physiol Heart Circ Physiol; 2012 Mar 15; 302(6):H1347-54. PubMed ID: 22268103
    [Abstract] [Full Text] [Related]

  • 10. The bradykinin-cGMP-PKG pathway augments insulin sensitivity via upregulation of MAPK phosphatase-5 and inhibition of JNK.
    Frigolet ME, Thomas G, Beard K, Lu H, Liu L, Fantus IG.
    Am J Physiol Endocrinol Metab; 2017 Sep 01; 313(3):E321-E334. PubMed ID: 28679626
    [Abstract] [Full Text] [Related]

  • 11. Soluble guanylate cyclase as a novel treatment target for osteoporosis.
    Joshua J, Schwaerzer GK, Kalyanaraman H, Cory E, Sah RL, Li M, Vaida F, Boss GR, Pilz RB.
    Endocrinology; 2014 Dec 01; 155(12):4720-30. PubMed ID: 25188528
    [Abstract] [Full Text] [Related]

  • 12. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
    Loganathan S, Korkmaz-Icöz S, Radovits T, Li S, Mikles B, Barnucz E, Hirschberg K, Karck M, Szabó G.
    J Heart Lung Transplant; 2015 Oct 01; 34(10):1346-53. PubMed ID: 26210750
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
    Korkmaz S, Radovits T, Barnucz E, Hirschberg K, Neugebauer P, Loganathan S, Veres G, Páli S, Seidel B, Zöllner S, Karck M, Szabó G.
    Circulation; 2009 Aug 25; 120(8):677-86. PubMed ID: 19667237
    [Abstract] [Full Text] [Related]

  • 14. Pharmic Activation of PKG2 Alleviates Diabetes-Induced Osteoblast Dysfunction by Suppressing PLCβ1-Ca2+-Mediated Endoplasmic Reticulum Stress.
    Jia T, Wang YN, Feng Y, Wang C, Zhang D, Xu X.
    Oxid Med Cell Longev; 2021 Aug 25; 2021():5552530. PubMed ID: 34221234
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
    Korkmaz S, Loganathan S, Mikles B, Radovits T, Barnucz E, Hirschberg K, Li S, Hegedüs P, Páli S, Weymann A, Karck M, Szabó G.
    J Cardiovasc Pharmacol Ther; 2013 Jan 25; 18(1):70-7. PubMed ID: 22914857
    [Abstract] [Full Text] [Related]

  • 16. Dioscin Attenuates Myocardial Damages in Diabetic Rats maybe by Regulating NO-sGC-cGMP-PKG Pathway.
    Wei Q, Zhu T, Xiao X, Sun L, Zhang Z, Huang T.
    Ann Clin Lab Sci; 2019 Jan 25; 49(1):97-104. PubMed ID: 30814084
    [Abstract] [Full Text] [Related]

  • 17. Inonotus obliquus (Chaga) against HFD/STZ-induced glucolipid metabolism disorders and abnormal renal functions by regulating NOS-cGMP-PDE5 signaling pathway.
    Feng Y, Liu J, Gong L, Han Z, Zhang Y, Li R, Liao H.
    Chin J Nat Med; 2024 Jul 25; 22(7):619-631. PubMed ID: 39059831
    [Abstract] [Full Text] [Related]

  • 18. Effects of low-dose insulin or a soluble guanylate cyclase activator on lower urinary tract dysfunction in streptozotocin-induced diabetic rats.
    Gotoh D, Cao N, Alexandre EC, Saito T, Morizawa Y, Hori S, Miyake M, Torimoto K, Fujimoto K, Yoshimura N.
    Life Sci; 2021 Dec 01; 286():120001. PubMed ID: 34614417
    [Abstract] [Full Text] [Related]

  • 19. Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway.
    Fleischmann D, Harloff M, Maslanka Figueroa S, Schlossmann J, Goepferich A.
    Int J Mol Sci; 2021 Mar 04; 22(5):. PubMed ID: 33806499
    [Abstract] [Full Text] [Related]

  • 20. Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats.
    Hoffmann LS, Kretschmer A, Lawrenz B, Hocher B, Stasch JP.
    PLoS One; 2015 Mar 04; 10(12):e0145048. PubMed ID: 26717150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.